David Dodick

TitleAdjunct Faculty
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
AddressNA
Phone925-0002
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schwedt TJ, Hentz JG, Sahai-Srivastava S, Spare NM, Martin VT, Treppendahl C, Digre K, Bennett NL, Birlea M, Watson D, Murinova N, Robert T, Dodick DW. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021 Jan 12. PMID: 33432635.
      Citations:    
    2. Ashina M, Goadsby PJ, Reuter U, Silberstein S, Dodick DW, Xue F, Zhang F, Paiva da Silva Lima G, Cheng S, Mikol DD. Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial. Eur J Neurol. 2021 Jan 05. PMID: 33400330.
      Citations:    
    3. Lipton RB, Buse DC, Dodick DW, Schwedt TJ, Singh P, Munjal S, Fanning K, Bostic Bs R, Reed ML. Burden of increasing opioid use in the treatment of migraine: Results from the Migraine in America Symptoms and Treatment Study. Headache. 2020 Dec 16. PMID: 33326608.
      Citations:    
    4. Lipton RB, Tepper SJ, Silberstein SD, Kudrow D, Ashina M, Reuter U, Dodick DW, Zhang F, Rippon GA, Cheng S, Mikol DD. Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension. Cephalalgia. 2021 Jan; 41(1):6-16. PMID: 33269951.
      Citations:    
    5. Goadsby PJ, Blumenfeld AM, Lipton RB, Dodick DW, Kalidas K, M Adams A, Jakate A, Liu C, Szegedi A, Trugman JM. Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications. Cephalalgia. 2020 Nov 26; 333102420970523. PMID: 33241721.
      Citations:    
    6. Dodick DW, Gottschalk C, Cady R, Hirman J, Smith J, Snapinn S. Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache. 2020 Nov; 60(10):2220-2231. PMID: 33165938.
      Citations:    
    7. Dodick DW, Doty EG, Aurora SK, Ruff DD, Stauffer VL, Jedynak J, Dong Y, Pearlman EM. Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine. Cephalalgia. 2020 Nov 03; 333102420966658. PMID: 33143451.
      Citations:    
    8. Kopruszinski CM, Thornton P, Arnold J, Newton P, Lowne D, Navratilova E, Swiokla J, Dodick DW, Dobson C, Gurrell I, Chessell IP, Porreca F. Characterization and preclinical evaluation of a protease activated receptor 2 (PAR2) monoclonal antibody as a preventive therapy for migraine. Cephalalgia. 2020 Dec; 40(14):1535-1550. PMID: 33131305.
      Citations:    
    9. Silberstein SD, Diener HC, Dodick DW, Manack Adams A, DeGryse RE, Lipton RB. The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine. Pain Ther. 2020 Dec; 9(2):695-707. PMID: 33026630.
      Citations:    
    10. Diener HC, Dodick DW, Lipton RB, Manack Adams A, DeGryse RE, Silberstein SD. Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis. Pain Ther. 2020 Dec; 9(2):683-694. PMID: 33026631.
      Citations:    
    11. Kopruszinski CM, Navratilova E, Swiokla J, Dodick DW, Chessell IP, Porreca F. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Cephalalgia. 2020 Sep 26; 333102420959794. PMID: 32985222.
      Citations:    
    12. Ishii R, Schwedt TJ, Kim SK, Dumkrieger G, Chong CD, Dodick DW. Effect of Migraine on Pregnancy Planning: Insights From the American Registry for Migraine Research. Mayo Clin Proc. 2020 10; 95(10):2079-2089. PMID: 32948327.
      Citations:    
    13. Goadsby PJ, Silberstein SD, Yeung PP, Cohen JM, Ning X, Yang R, Dodick DW. Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study. Neurology. 2020 11 03; 95(18):e2487-e2499. PMID: 32913018.
      Citations:    
    14. Goadsby PJ, Dodick DW, Ailani J, Trugman JM, Finnegan M, Lu K, Szegedi A. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial. Lancet Neurol. 2020 09; 19(9):727-737. PMID: 32822633.
      Citations:    
    15. Broessner G, Reuter U, Bonner JH, Dodick DW, Hallström Y, Picard H, Zhang F, Lenz RA, Klatt J, Mikol DD. The Spectrum of Response to Erenumab in Patients With Episodic Migraine and Subgroup Analysis of Patients Achieving =50%, =75%, and 100% Response. Headache. 2020 Aug 26. PMID: 32851644.
      Citations:    
    16. Shibata M, Tsutsumi K, Iwabuchi Y, Kameyama M, Takizawa T, Nakahara T, Fujiwara H, Jinzaki M, Nakahara J, Dodick DW. [123I]-IMP single-photon emission computed tomography imaging in visual snow syndrome: A case series. Cephalalgia. 2020 Aug 13; 333102420950454. PMID: 32791921.
      Citations:    
    17. Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ. Impact of Depression and Anxiety Symptoms on Patient-Reported Outcomes in Patients With Migraine: Results From the American Registry for Migraine Research (ARMR). Headache. 2020 Aug 04. PMID: 32749685.
      Citations:    
    18. Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Houle TT, Hoek TCVD, Martinelli D, Terwindt GM. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults. Cephalalgia. 2020 Sep; 40(10):1026-1044. PMID: 32722936.
      Citations:    
    19. Saffi H, Do TP, Hansen JM, Dodick DW, Ashina M. The migraine landscape on YouTube: A review of YouTube as a source of information on migraine. Cephalalgia. 2020 Jul 23; 333102420943891. PMID: 32703016.
      Citations:    
    20. Bojazar R, Do TP, Hansen JM, Dodick DW, Ashina M. Googling migraine: A study of Google as an information resource of migraine management. Cephalalgia. 2020 Jul 23; 333102420942241. PMID: 32703015.
      Citations:    
    21. Navratilova E, Behravesh S, Oyarzo J, Dodick DW, Banerjee P, Porreca F. Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia. 2020 Aug; 40(9):892-902. PMID: 32615788.
      Citations:    
    22. Crespi J, Bratbak D, Dodick DW, Matharu M, Solheim O, Gulati S, Berntsen EM, Tronvik E. Open-Label, Multi-Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache. Headache. 2020 Jun 25. PMID: 32583902.
      Citations:    
    23. Rau JC, Navratilova E, Oyarzo J, Johnson KW, Aurora SK, Schwedt TJ, Dodick DW, Porreca F. Evaluation of LY573144 (lasmiditan) in a preclinical model of medication overuse headache. Cephalalgia. 2020 Aug; 40(9):903-912. PMID: 32580575.
      Citations:    
    24. Dodick DW, Ashina M, Sakai F, Grisold W, Miyake H, Henscheid-Lorenz D, Craven A, Ruiz de la Torre E, Koh R, Reznik N, Bance L, Leroux E, Edvinsson L. Vancouver Declaration II on Global Headache Patient Advocacy 2019. Cephalalgia. 2020 Sep; 40(10):1017-1025. PMID: 32345038.
      Citations:    
    25. Øie LR, Kurth T, Gulati S, Dodick DW. Migraine and risk of stroke. J Neurol Neurosurg Psychiatry. 2020 Jun; 91(6):593-604. PMID: 32217787.
      Citations:    
    26. Lipton RB, Marcus SC, Shewale AR, Dodick DW, Viswanathan HN, Doshi JA. Acute treatment patterns in patients with migraine newly initiating a triptan. Cephalalgia. 2020 Apr; 40(5):437-447. PMID: 32138526.
      Citations:    
    27. Buse DC, Reed ML, Fanning KM, Bostic R, Dodick DW, Schwedt TJ, Munjal S, Singh P, Lipton RB. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2020 Mar 02; 21(1):23. PMID: 32122324.
      Citations:    
    28. Goadsby PJ, Rezai AR, Dodick DW. The need for continued care after sponsor closure - Authors' reply. Lancet Neurol. 2020 03; 19(3):205-206. PMID: 32085831.
      Citations:    
    29. Dodick DW, Lipton RB, Ailani J, Halker Singh RB, Shewale AR, Zhao S, Trugman JM, Yu SY, Viswanathan HN. Ubrogepant, an Acute Treatment for Migraine, Improved Patient-Reported Functional Disability and Satisfaction in 2 Single-Attack Phase 3 Randomized Trials, ACHIEVE I and II. Headache. 2020 Apr; 60(4):686-700. PMID: 32073660.
      Citations:    
    30. Dodick DW, Goadsby PJ, Lucas C, Jensen R, Bardos JN, Martinez JM, Zhou C, Aurora SK, Yang JY, Conley RR, Oakes T. Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment. Cephalalgia. 2020 Aug; 40(9):935-948. PMID: 32050782.
      Citations:    
    31. Pearl TA, Dumkrieger G, Chong CD, Dodick DW, Schwedt TJ. Sensory Hypersensitivity Symptoms in Migraine With vs Without Aura: Results From the American Registry for Migraine Research. Headache. 2020 Mar; 60(3):506-514. PMID: 31965576.
      Citations:    
    32. Dodick DW, Ailani J. Clinical Efficacy and Safety of Ubrogepant for the Acute Treatment of Migraine. J Fam Pract. 2020 Jan/Feb; 69(1 Suppl):S13-S22. PMID: 32053715.
      Citations:    
    33. Dodick DW, Shewale AS, Lipton RB, Baum SJ, Marcus SC, Silberstein SD, Pavlovic JM, Bennett NL, Young WB, Viswanathan HN, Doshi JA, Weintraub H. Migraine Patients With Cardiovascular Disease and Contraindications: An Analysis of Real-World Claims Data. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720963680. PMID: 33095099.
      Citations:    
    34. Kudrow D, Pascual J, Winner PK, Dodick DW, Tepper SJ, Reuter U, Hong F, Klatt J, Zhang F, Cheng S, Picard H, Eisele O, Wang J, Latham JN, Mikol DD. Vascular safety of erenumab for migraine prevention. Neurology. 2020 02 04; 94(5):e497-e510. PMID: 31852816.
      Citations:    
    35. Munjal S, Singh P, Reed ML, Fanning K, Schwedt TJ, Dodick DW, Buse DC, Lipton RB. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study. Headache. 2020 Feb; 60(2):416-429. PMID: 31837007.
      Citations:    
    36. Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Ubrogepant for the Treatment of Migraine. N Engl J Med. 2019 12 05; 381(23):2230-2241. PMID: 31800988.
      Citations:    
    37. Goadsby PJ, Sahai-Srivastava S, Kezirian EJ, Calhoun AH, Matthews DC, McAllister PJ, Costantino PD, Friedman DI, Zuniga JR, Mechtler LL, Popat SR, Rezai AR, Dodick DW. Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial. Lancet Neurol. 2019 12; 18(12):1081-1090. PMID: 31701891.
      Citations:    
    38. Schwedt TJ, Digre K, Tepper SJ, Spare NM, Ailani J, Birlea M, Burish M, Mechtler L, Gottschalk C, Quinn AM, McGillicuddy L, Bance L, Dumkrieger G, Chong CD, Dodick DW. The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort. Headache. 2019 Nov 22. PMID: 31755111.
      Citations:    
    39. Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, Trugman JM. Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial. JAMA. 2019 11 19; 322(19):1887-1898. PMID: 31742631.
      Citations:    
    40. Detke HC, Millen BA, Zhang Q, Samaan K, Ailani J, Dodick DW, Aurora SK. Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies. Headache. 2020 Feb; 60(2):348-359. PMID: 31710104.
      Citations:    
    41. Lipton RB, Munjal S, Brand-Schieber E, Tepper SJ, Dodick DW. Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. Headache. 2020 01; 60(1):58-70. PMID: 31647577.
      Citations:    
    42. Navratilova E, Rau J, Oyarzo J, Tien J, Mackenzie K, Stratton J, Remeniuk B, Schwedt T, Anderson T, Dodick D, Porreca F. CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice. Cephalalgia. 2019 Dec; 39(14):1762-1775. PMID: 31550910.
      Citations:    
    43. Chalmer MA, Hansen TF, Lebedeva ER, Dodick DW, Lipton RB, Olesen J. Proposed new diagnostic criteria for chronic migraine. Cephalalgia. 2020 04; 40(4):399-406. PMID: 31544467.
      Citations:    
    44. Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW, Dodick DW. Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol. 2019 10; 15(10):607-617. PMID: 31527806.
      Citations:    
    45. Lipton RB, Munjal S, Buse DC, Alam A, Fanning KM, Reed ML, Schwedt TJ, Dodick DW. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study. Headache. 2019 09; 59(8):1310-1323. PMID: 31410844.
      Citations:    
    46. Crespi J, Bratbak D, Dodick DW, Matharu M, Jamtøy KA, Tronvik E. Pilot Study of Injection of OnabotulinumtoxinA Toward the Sphenopalatine Ganglion for the Treatment of Classical Trigeminal Neuralgia. Headache. 2019 09; 59(8):1229-1239. PMID: 31342515.
      Citations:    
    47. Kopruszinski CM, Navratilova E, Vagnerova B, Swiokla J, Patwardhan A, Dodick D, Porreca F. Cannabinoids induce latent sensitization in a preclinical model of medication overuse headache. Cephalalgia. 2020 01; 40(1):68-78. PMID: 31311288.
      Citations:    
    48. Goadsby PJ, Dodick DW, Leone M, Bardos JN, Oakes TM, Millen BA, Zhou C, Dowsett SA, Aurora SK, Ahn AH, Yang JY, Conley RR, Martinez JM. Trial of Galcanezumab in Prevention of Episodic Cluster Headache. N Engl J Med. 2019 07 11; 381(2):132-141. PMID: 31291515.
      Citations:    
    49. Dodick DW, Lipton RB, Silberstein S, Goadsby PJ, Biondi D, Hirman J, Cady R, Smith J. Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial. Cephalalgia. 2019 Aug; 39(9):1075-1085. PMID: 31234642.
      Citations:    
    50. Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep; 18(9):891-902. PMID: 31174999.
      Citations:    
    51. Ashina M, Goadsby PJ, Reuter U, Silberstein S, Dodick D, Rippon GA, Klatt J, Xue F, Chia V, Zhang F, Cheng S, Mikol DD. Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine. Cephalalgia. 2019 May 30; 333102419854082. PMID: 31146544.
      Citations:    
    52. Dodick DW, Silberstein SD, Lipton RB, DeGryse RE, Adams AM, Diener HC. Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data. Cephalalgia. 2019 Jul; 39(8):945-956. PMID: 31112399.
      Citations:    
    53. Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019 May 09. PMID: 31074005.
      Citations:    
    54. Goadsby PJ, Dodick DW, Martinez JM, Ferguson MB, Oakes TM, Zhang Q, Skljarevski V, Aurora SK. Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis. J Neurol Neurosurg Psychiatry. 2019 08; 90(8):939-944. PMID: 31004075.
      Citations:    
    55. Stern RA, Adler CH, Chen K, Navitsky M, Luo J, Dodick DW, Alosco ML, Tripodis Y, Goradia DD, Martin B, Mastroeni D, Fritts NG, Jarnagin J, Devous MD, Mintun MA, Pontecorvo MJ, Shenton ME, Reiman EM. Tau Positron-Emission Tomography in Former National Football League Players. N Engl J Med. 2019 05 02; 380(18):1716-1725. PMID: 30969506.
      Citations:    
    56. Rau JC, Dodick DW. Other Preventive Anti-Migraine Treatments: ACE Inhibitors, ARBs, Calcium Channel Blockers, Serotonin Antagonists, and NMDA Receptor Antagonists. Curr Treat Options Neurol. 2019 Mar 18; 21(4):17. PMID: 30880363.
      Citations:    
    57. Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition. Cephalalgia. 2019 Feb 26; 333102419828967. PMID: 30806518.
      Citations:    
    58. Dodick DW, Reed ML, Fanning KM, Munjal S, Alam A, Buse DC, Schwedt TJ, Lipton RB. Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study. Cephalalgia. 2019 06; 39(7):873-882. PMID: 30732460.
      Citations:    
    59. Tepper SJ, Dodick DW, Schmidt PC, Kellerman DJ. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches. Headache. 2019 04; 59(4):509-517. PMID: 30698272.
      Citations:    
    60. Dodick DW. CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications. Cephalalgia. 2019 03; 39(3):445-458. PMID: 30661365.
      Citations:    
    61. Lipton RB, Munjal S, Alam A, Buse DC, Fanning KM, Reed ML, Schwedt TJ, Dodick DW. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences. Headache. 2018 Oct; 58(9):1408-1426. PMID: 30341895.
      Citations:    
    62. Nation KM, Dodick DW, Navratilova E, Porreca F. Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache. Cephalalgia. 2019 04; 39(5):617-625. PMID: 30286616.
      Citations:    
    63. Dodick DW, Tepper SJ, Lipton RB, Buse DC, Stewart WF, Bayliss M, Desai P, Sapra S, Anderson K, McInerney-Prichard E. Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker. Headache. 2018 Oct; 58(9):1358-1372. PMID: 30362524.
      Citations:    
    64. Øie LR, Madsbu MA, Solheim O, Jakola AS, Giannadakis C, Vorhaug A, Padayachy L, Jensberg H, Dodick D, Salvesen Ø, Gulati S. Functional outcome and survival following spontaneous intracerebral hemorrhage: A retrospective population-based study. Brain Behav. 2018 10; 8(10):e01113. PMID: 30240164.
      Citations:    
    65. Stauffer VL, Dodick DW, Zhang Q, Carter JN, Ailani J, Conley RR. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial. JAMA Neurol. 2018 09 01; 75(9):1080-1088. PMID: 29813147.
      Citations:    
    66. VanderPluym J, Dodick DW, Lipton RB, Ma Y, Loupe PS, Bigal ME. Fremanezumab for preventive treatment of migraine: Functional status on headache-free days. Neurology. 2018 09 18; 91(12):e1152-e1165. PMID: 30120138.
      Citations:    
    67. Si B, Dumkrieger G, Wu T, Zafonte R, Valadka AB, Okonkwo DO, Manley GT, Wang L, Dodick DW, Schwedt TJ, Li J. Sub-classifying patients with mild traumatic brain injury: A clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes. PLoS One. 2018; 13(7):e0198741. PMID: 29995912.
      Citations:    
    68. Dodick D, Edvinsson L, Makino T, Grisold W, Sakai F, Jensen R, Balch A, Ruiz de la Torre E, Henscheid-Lorenz D, Craven A, Ashina M. Vancouver Declaration on Global Headache Patient Advocacy 2018. Cephalalgia. 2018 11; 38(13):1899-1909. PMID: 29882695.
      Citations:    
    69. Schwedt TJ, Alam A, Reed ML, Fanning KM, Munjal S, Buse DC, Dodick DW, Lipton RB. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24; 19(1):38. PMID: 29797100.
      Citations:    
    70. Dodick DW, Tepper SJ, Friedman DI, Gelfand AA, Kellerman DJ, Schmidt PC. Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial. Headache. 2018 Jul; 58(7):986-992. PMID: 29782049.
      Citations:    
    71. Chen TY, Garza I, Dodick DW, Robertson CE. The Effect of OnabotulinumtoxinA on Aura Frequency and Severity in Patients With Hemiplegic Migraine: Case Series of 11 Patients. Headache. 2018 Jul; 58(7):973-985. PMID: 29762872.
      Citations:    
    72. Dodick DW, Silberstein SD, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial. JAMA. 2018 05 15; 319(19):1999-2008. PMID: 29800211.
      Citations:    
    73. Halker Singh RB, Aycardi E, Bigal ME, Loupe PS, McDonald M, Dodick DW. Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials. Cephalalgia. 2019 01; 39(1):52-60. PMID: 29722276.
      Citations:    
    74. Dodick DW. A Phase-by-Phase Review of Migraine Pathophysiology. Headache. 2018 05; 58 Suppl 1:4-16. PMID: 29697154.
      Citations:    
    75. Lipton RB, Brennan A, Palmer S, Hatswell AJ, Porter JK, Sapra S, Villa G, Shah N, Tepper S, Dodick D. Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. J Med Econ. 2018 Jul; 21(7):666-675. PMID: 29571276.
      Citations:    
    76. Dodick DW. Migraine. Lancet. 2018 03 31; 391(10127):1315-1330. PMID: 29523342.
      Citations:    
    77. Dodick DW, Ashina M, Brandes JL, Kudrow D, Lanteri-Minet M, Osipova V, Palmer K, Picard H, Mikol DD, Lenz RA. ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia. 2018 05; 38(6):1026-1037. PMID: 29471679.
      Citations:    
    78. Crespi J, Bratbak D, Dodick D, Matharu M, Jamtøy KA, Aschehoug I, Tronvik E. Measurement and implications of the distance between the sphenopalatine ganglion and nasal mucosa: a neuroimaging study. J Headache Pain. 2018 Feb 13; 19(1):14. PMID: 29442191.
      Citations:    
    79. Skljarevski V, Oakes TM, Zhang Q, Ferguson MB, Martinez J, Camporeale A, Johnson KW, Shan Q, Carter J, Schacht A, Goadsby PJ, Dodick DW. Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial. JAMA Neurol. 2018 02 01; 75(2):187-193. PMID: 29255900.
      Citations:    
    80. Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018 Jan 01; 333102418762525. PMID: 29504483.
      Citations:    
    81. Tassorelli C, Diener HC, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults. Cephalalgia. 2018 Jan 01; 333102418758283. PMID: 29504482.
      Citations:    
    82. Dodick DW. Academic dissertations from the Danish Headache Center 1980-2016. Cephalalgia. 2017 12; 37(2_suppl):3. PMID: 29256258.
      Citations:    
    83. Dhawan PS, Leong D, Tapsell L, Starling AJ, Galetta SL, Balcer LJ, Overall TL, Adler JS, Halker-Singh RB, Vargas BB, Dodick D. King-Devick Test identifies real-time concussion and asymptomatic concussion in youth athletes. Neurol Clin Pract. 2017 Dec; 7(6):464-473. PMID: 29431168.
      Citations:    
    84. Silberstein SD, Dodick DW, Bigal ME, Yeung PP, Goadsby PJ, Blankenbiller T, Grozinski-Wolff M, Yang R, Ma Y, Aycardi E. Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med. 2017 11 30; 377(22):2113-2122. PMID: 29171818.
      Citations:    
    85. Silberstein SD, Calhoun AH, Treppendahl C, Dodick DW, Rapoport AM, Mamidi A, Vargas P, Ebert TH, Tepper SJ. The emerging role of gammaCore® in the management of cluster headache: expert panel recommendations. Am J Manag Care. 2017 Nov; 23(17 Suppl):S326-S333. PMID: 29144718.
      Citations:    
    86. Dodick DW. Board Walk - September 2017. Cephalalgia. 2017 Sep; 37(10):1009-1010. PMID: 28885053.
      Citations:    
    87. Smith AM, Stuart MJ, Roberts WO, Dodick DW, Finnoff JT, Jorgensen JK, Krause DA. Concussion in Ice Hockey: Current Gaps and Future Directions in an Objective Diagnosis. Clin J Sport Med. 2017 Sep; 27(5):503-509. PMID: 28079758.
      Citations:    
    88. Cohen JM, Dodick DW, Yang R, Newman LC, Li T, Aycardi E, Bigal ME. Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines. Headache. 2017 Oct; 57(9):1375-1384. PMID: 28862758.
      Citations:    
    89. Ashina M, Dodick D, Goadsby PJ, Reuter U, Silberstein S, Zhang F, Gage JR, Cheng S, Mikol DD, Lenz RA. Erenumab (AMG 334) in episodic migraine: Interim analysis of an ongoing open-label study. Neurology. 2017 Sep 19; 89(12):1237-1243. PMID: 28835404.
      Citations:    
    90. Goadsby PJ, Dodick DW, Lipton RB. Re: Placebo responses in device studies. Cephalalgia. 2018 04; 38(5):1007-1008. PMID: 28747062.
      Citations:    
    91. Blumenfeld AM, Silberstein SD, Dodick DW, Aurora SK, Brin MF, Binder WJ. Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes. Headache. 2017 May; 57(5):766-777. PMID: 28387038.
      Citations:    
    92. Xie JY, De Felice M, Kopruszinski CM, Eyde N, LaVigne J, Remeniuk B, Hernandez P, Yue X, Goshima N, Ossipov M, King T, Streicher JM, Navratilova E, Dodick D, Rosen H, Roberts E, Porreca F. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Cephalalgia. 2017 Jul; 37(8):780-794. PMID: 28376659.
      Citations:    
    93. Orr SL, Ramsay T, Christie SN, Dodick D, Gladstone J, Dowlatshahi D. The Non-Inferiority Margins in Migraine Research (NIMM) Survey. Headache. 2017 May; 57(5):729-736. PMID: 28188613.
      Citations:    
    94. Rice FL, Xie JY, Albrecht PJ, Acker E, Bourgeois J, Navratilova E, Dodick DW, Porreca F. Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine. Cephalalgia. 2017 Dec; 37(14):1350-1372. PMID: 27852962.
      Citations:    
    95. Hepp Z, Dodick DW, Varon SF, Chia J, Matthew N, Gillard P, Hansen RN, Devine EB. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis. Cephalalgia. 2017 Apr; 37(5):470-485. PMID: 27837173.
      Citations:    
    96. Dodick D, Starling AJ, Wethe J, Pang Y, Messner LV, Smith C, Master CL, Halker-Singh RB, Vargas BB, Bogle JM, Mandrekar J, Talaber A, Leong D. The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students. J Child Neurol. 2017 01; 32(1):104-111. PMID: 28257277.
      Citations:    
    97. Von Korff M, Scher AI, Helmick C, Carter-Pokras O, Dodick DW, Goulet J, Hamill-Ruth R, LeResche L, Porter L, Tait R, Terman G, Veasley C, Mackey S. United States National Pain Strategy for Population Research: Concepts, Definitions, and Pilot Data. J Pain. 2016 10; 17(10):1068-1080. PMID: 27377620.
      Citations:    
    98. Chong CD, Schwedt TJ, Dodick DW. Migraine: What Imaging Reveals. Curr Neurol Neurosci Rep. 2016 07; 16(7):64. PMID: 27181270.
      Citations:    
    99. Bigal ME, Dodick DW, Krymchantowski AV, VanderPluym JH, Tepper SJ, Aycardi E, Loupe PS, Ma Y, Goadsby PJ. TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points. Neurology. 2016 Jul 05; 87(1):41-8. PMID: 27281531.
      Citations:    
    100. Voss T, Lipton RB, Dodick DW, Dupre N, Ge JY, Bachman R, Assaid C, Aurora SK, Michelson D. A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia. 2016 Aug; 36(9):887-98. PMID: 27269043.
      Citations:    
    101. Kopruszinski CM, Xie JY, Eyde NM, Remeniuk B, Walter S, Stratton J, Bigal M, Chichorro JG, Dodick D, Porreca F. Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents. Cephalalgia. 2017 May; 37(6):560-570. PMID: 27206958.
      Citations:    
    102. Bratbak DF, Nordgård S, Stovner LJ, Linde M, Dodick DW, Aschehoug I, Folvik M, Tronvik E. Pilot study of sphenopalatine injection of onabotulinumtoxinA for the treatment of intractable chronic migraine. Cephalalgia. 2017 Apr; 37(4):356-364. PMID: 27154997.
      Citations:    
    103. Dodick DW, Loder EW, Manack Adams A, Buse DC, Fanning KM, Reed ML, Lipton RB. Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2016 May; 56(5):821-834. PMID: 27143127.
      Citations:    
    104. Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, Lipton RB. Impact of Migraine on the Family: Perspectives of People With Migraine and Their Spouse/Domestic Partner in the CaMEO Study. Mayo Clin Proc. 2016 Apr 25. PMID: 27132088.
      Citations:    
    105. Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, Saper J, Cady R, Chon Y, Dietrich J, Lenz R. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016 Apr; 15(4):382-90. PMID: 26879279.
      Citations:    
    106. Hepp Z, Rosen NL, Gillard PG, Varon SF, Mathew N, Dodick DW. Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database. Cephalalgia. 2016 Aug; 36(9):862-74. PMID: 26692400.
      Citations:    
    107. Diener HC, Dodick DW. Headache research in 2015: progress in migraine treatment. Lancet Neurol. 2016 Jan; 15(1):4-5. PMID: 26700894.
      Citations:    
    108. Dodick DW. Letter from the Editor-in-Chief. Cephalalgia. 2015 Dec; 35(14):1239. PMID: 26574595.
      Citations:    
    109. Dilli E, Dodick D. Reply to Dr. Merry's Letter to the Editor. Cephalalgia. 2016 08; 36(9):910. PMID: 26566934.
      Citations:    
    110. Bigal ME, Dodick DW, Rapoport AM, Silberstein SD, Ma Y, Yang R, Loupe PS, Burstein R, Newman LC, Lipton RB. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol. 2015 Nov; 14(11):1081-90. PMID: 26432182.
      Citations:    
    111. Robbins MS, Robertson CE, Ailani J, Levin M, Friedman DI, Dodick DW. Procedural Headache Medicine in Neurology Residency Training: A Survey of US Program Directors. Headache. 2016 Jan; 56(1):79-85. PMID: 26352267.
      Citations:    
    112. Schwedt TJ, Green AL, Dodick DW. Occipital Nerve Stimulation for Migraine: Update from Recent Multicenter Trials. Prog Neurol Surg. 2015; 29:117-26. PMID: 26393345.
      Citations:    
    113. Borsook D, Dodick DW. Taking the headache out of migraine. Neurol Clin Pract. 2015 Aug; 5(4):317-325. PMID: 26335578.
      Citations:    
    114. Dodick DW. IHS: sustaining momentum, fostering collaboration, facilitating advocacy. Cephalalgia. 2015 Jul; 35(8):737. PMID: 26059460.
      Citations:    
    115. Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016 Apr; 36(4):371-86. PMID: 26122645.
      Citations:    
    116. Lipton RB, Serrano D, Buse DC, Pavlovic JM, Blumenfeld AM, Dodick DW, Aurora SK, Becker WJ, Diener HC, Wang SJ, Vincent MB, Hindiyeh NA, Starling AJ, Gillard PJ, Varon SF, Reed ML. Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM). Cephalalgia. 2016 Mar; 36(3):203-15. PMID: 26002700.
      Citations:    
    117. Dilli E, Dodick DW. Response to Letter to the Editor. Cephalalgia. 2015 Oct; 35(11):1034-5. PMID: 25978932.
      Citations:    
    118. Jones LK, Dimberg EL, Boes CJ, Eggers SD, Dodick DW, Cutsforth-Gregory JK, Leep Hunderfund AN, Capobianco DJ. Milestone-compatible neurology resident assessments: A role for observable practice activities. Neurology. 2015 Jun 02; 84(22):2279-83. PMID: 25934848.
      Citations:    
    119. Starling AJ, Dodick DW. Best practices for patients with chronic migraine: burden, diagnosis, and management in primary care. Mayo Clin Proc. 2015 Mar; 90(3):408-14. PMID: 25744118.
      Citations:    
    120. Smith AM, Stuart MJ, Dodick DW, Roberts WO, Alford PW, Ashare AB, Aubrey M, Benson BW, Burke CJ, Dick R, Eickhoff C, Emery CA, Flashman LA, Gaz DV, Giza CC, Greenwald RM, Herring SA, Hoshizaki TB, Hudziak JJ, Huston J, Krause D, LaVoi N, Leaf M, Leddy JJ, MacPherson A, McKee AC, Mihalik JP, Moessner AM, Montelpare WJ, Putukian M, Schneider KJ, Szalkowski R, Tabrum M, Whitehead JR, Wiese-Bjornstal DM. Ice Hockey Summit II: zero tolerance for head hits and fighting. Curr Sports Med Rep. 2015 Mar-Apr; 14(2):135-44. PMID: 25757010.
      Citations:    
    121. Kurth T, Dodick DW. Migraine and the vascular system: much has been learned but still a long way to go. Cephalalgia. 2015 Feb; 35(2):83-4. PMID: 25613014.
      Citations:    
    122. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Site of effect of LY2951742 for migraine prophylaxis--authors' reply. Lancet Neurol. 2015 Jan; 14(1):32-3. PMID: 25496895.
      Citations:    
    123. Schwedt TJ, Chiang CC, Chong CD, Dodick DW. Functional MRI of migraine. Lancet Neurol. 2015 Jan; 14(1):81-91. PMID: 25496899.
      Citations:    
    124. Silberstein SD, Dodick DW, Aurora SK, Diener HC, DeGryse RE, Lipton RB, Turkel CC. Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT. J Neurol Neurosurg Psychiatry. 2015 Sep; 86(9):996-1001. PMID: 25500317.
      Citations:    
    125. Vongvaivanich K, Lertakyamanee P, Silberstein SD, Dodick DW. Late-life migraine accompaniments: A narrative review. Cephalalgia. 2015 Sep; 35(10):894-911. PMID: 25505036.
      Citations:    
    126. Dilli E, Halker R, Vargas B, Hentz J, Radam T, Rogers R, Dodick D. Occipital nerve block for the short-term preventive treatment of migraine: A randomized, double-blinded, placebo-controlled study. Cephalalgia. 2015 Oct; 35(11):959-68. PMID: 25505035.
      Citations:    
    127. Dodick DW, Turkel CC, DeGryse RE, Diener HC, Lipton RB, Aurora SK, Nolan ME, Silberstein SD. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example. J Pain. 2015 Feb; 16(2):164-75. PMID: 25464159.
      Citations:    
    128. Dodick DW, Stuart MJ, Smith AM. In response to: time to re-think the Zurich Guidelines? A critique on the consensus statement on concussion in Sport: the 4th International Conference on Concussion in Sport, held in Zurich, November 2012. Clin J Sport Med. 2014 Nov; 24(6):521. PMID: 25347263.
      Citations:    
    129. Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol. 2014 Nov; 13(11):1100-7. PMID: 25297013.
      Citations:    
    130. Lal D, Rounds A, Dodick DW. Comprehensive management of patients presenting to the otolaryngologist for sinus pressure, pain, or headache. Laryngoscope. 2015 Feb; 125(2):303-10. PMID: 25216102.
      Citations:    
    131. Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB. Adherence to oral migraine-preventive medications among patients with chronic migraine. Cephalalgia. 2015 May; 35(6):478-88. PMID: 25164920.
      Citations:    
    132. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2014 Sep; 13(9):885-92. PMID: 25127173.
      Citations:    
    133. Dodick DW, Silberstein SD, Reed KL, Deer TR, Slavin KV, Huh B, Sharan AD, Narouze S, Mogilner AY, Trentman TL, Ordia J, Vaisman J, Goldstein J, Mekhail N. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Long-term results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2015 Apr; 35(4):344-58. PMID: 25078718.
      Citations:    
    134. Silberstein SD, Lipton RB, Dodick DW. Operational diagnostic criteria for chronic migraine: expert opinion. Headache. 2014 Jul; 54(7):1258-66. PMID: 24990187.
      Citations:    
    135. Orr SL, Aubé M, Becker WJ, Davenport WJ, Dilli E, Dodick D, Giammarco R, Gladstone J, Leroux E, Pim H, Dickinson G, Christie SN. Canadian Headache Society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2015 Mar; 35(3):271-84. PMID: 24875925.
      Citations:    
    136. Chong CD, Dodick DW, Schlaggar BL, Schwedt TJ. Atypical age-related cortical thinning in episodic migraine. Cephalalgia. 2014 Dec; 34(14):1115-24. PMID: 24781111.
      Citations:    
    137. Files JA, Schwedt TJ, Mayer AP, David PS, Vargas BB, Chang YH, Hunt M, Patel S, Ko MG, Tozer BS, Burstein R, Dodick DW. Imploding and exploding migraine headaches: comparison of methods to diagnose pain directionality. Headache. 2014 Jun; 54(6):1010-8. PMID: 24527766.
      Citations:    
    138. Zach KJ, Trentman TL, Zimmerman RS, Dodick DW. Refractory headaches treated with bilateral occipital and temporal region stimulation. Med Devices (Auckl). 2014; 7:55-9. PMID: 24707189.
      Citations:    
    139. Schwedt TJ, Chong CD, Chiang CC, Baxter L, Schlaggar BL, Dodick DW. Enhanced pain-induced activity of pain-processing regions in a case-control study of episodic migraine. Cephalalgia. 2014 Oct; 34(12):947-58. PMID: 24627432.
      Citations:    
    140. Baron EP, Markowitz SY, Lettich A, Hastriter E, Lovell B, Kalidas K, Dodick DW, Schwedt TJ. Triptan education and improving knowledge for optimal migraine treatment: an observational study. Headache. 2014 Apr; 54(4):686-97. PMID: 24520930.
      Citations:    
    141. Mathew PG, Pavlovic JM, Lettich A, Wells RE, Robertson CE, Mullin K, Charleston Iv L, Dodick DW, Schwedt TJ. Education and decision making at the time of triptan prescribing: patient expectations vs actual practice. Headache. 2014 Apr; 54(4):698-708. PMID: 24512184.
      Citations:    
    142. Green AL, Gu P, De Felice M, Dodick D, Ossipov MH, Porreca F. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Cephalalgia. 2014 Jul; 34(8):594-604. PMID: 24335852.
      Citations:    
    143. Dodick DW. Board walk - December 2013. Cephalalgia. 2013 Dec; 33(16):1360. PMID: 24231286.
      Citations:    
    144. Schwedt TJ, Zhou J, Dodick DW. Sporadic hemiplegic migraine with permanent neurological deficits. Headache. 2014 Jan; 54(1):163-6. PMID: 24117121.
      Citations:    
    145. Starling A, Hernandez F, Hoxworth JM, Trentman T, Halker R, Vargas BB, Hastriter E, Dodick D. Sensitivity of MRI of the spine compared with CT myelography in orthostatic headache with CSF leak. Neurology. 2013 Nov 12; 81(20):1789-92. PMID: 24107860.
      Citations:    
    146. Wells RE, Markowitz SY, Baron EP, Hentz JG, Kalidas K, Mathew PG, Halker R, Dodick DW, Schwedt TJ. Identifying the factors underlying discontinuation of triptans. Headache. 2014 Feb; 54(2):278-89. PMID: 24001117.
      Citations:    
    147. Marcus R, Goadsby PJ, Dodick D, Stock D, Manos G, Fischer TZ. BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia. 2014 Feb; 34(2):114-25. PMID: 23965396.
      Citations:    
    148. Silberstein SD, Dodick DW. Migraine Genetics: Part II. Headache. 2013 Sep; 53(8):1218-29. PMID: 23919895.
      Citations:    
    149. Silberstein S, Dodick D. Migraine genetics - a review: part I. Headache. 2013 Sep; 53(8):1207-17. PMID: 23848970.
      Citations:    
    150. Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, Degryse RE, Turkel CC, Dodick DW. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline. J Neurol Sci. 2013 Aug 15; 331(1-2):48-56. PMID: 23790235.
      Citations:    
    151. May A, Dodick D. Headache research: a string of pearls. Cephalalgia. 2013 Jun; 33(8):505. PMID: 23671247.
      Citations:    
    152. Yancy H, Lee-Iannotti JK, Schwedt TJ, Dodick DW. Reversible cerebral vasoconstriction syndrome. Headache. 2013 Mar; 53(3):570-6. PMID: 23489219.
      Citations:    
    153. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C. Author response. Neurology. 2013 Feb 26; 80(9):868-9. PMID: 23565553.
      Citations:    
    154. Blumenfeld A, Ashkenazi A, Napchan U, Bender SD, Klein BC, Berliner R, Ailani J, Schim J, Friedman DI, Charleston L, Young WB, Robertson CE, Dodick DW, Silberstein SD, Robbins MS. Expert consensus recommendations for the performance of peripheral nerve blocks for headaches - a narrative review. Headache. 2013 Mar; 53(3):437-46. PMID: 23406160.
      Citations:    
    155. Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Migraine headache is present in the aura phase: a prospective study. Neurology. 2012 Nov 13; 79(20):2044-9. PMID: 23115208.
      Citations:    
    156. Vargas BB, Channer DD, Dodick DW, Demaerschalk BM. Teleconcussion: an innovative approach to screening, diagnosis, and management of mild traumatic brain injury. Telemed J E Health. 2012 Dec; 18(10):803-6. PMID: 23101482.
      Citations:    
    157. Silberstein SD, Dodick DW, Saper J, Huh B, Slavin KV, Sharan A, Reed K, Narouze S, Mogilner A, Goldstein J, Trentman T, Vaisma J, Ordia J, Weber P, Deer T, Levy R, Diaz RL, Washburn SN, Mekhail N. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: Results from a randomized, multicenter, double-blinded, controlled study. Cephalalgia. 2012 Dec; 32(16):1165-79. PMID: 23034698.
      Citations:    
    158. Demaerschalk BM, Bobrow BJ, Raman R, Ernstrom K, Hoxworth JM, Patel AC, Kiernan TE, Aguilar MI, Ingall TJ, Dodick DW, Meyer BC. CT interpretation in a telestroke network: agreement among a spoke radiologist, hub vascular neurologist, and hub neuroradiologist. Stroke. 2012 Nov; 43(11):3095-7. PMID: 22984007.
      Citations:    
    159. Demaerschalk BM, Vargas JE, Channer DD, Noble BN, Kiernan TE, Gleason EA, Vargas BB, Ingall TJ, Aguilar MI, Dodick DW, Bobrow BJ. Smartphone teleradiology application is successfully incorporated into a telestroke network environment. Stroke. 2012 Nov; 43(11):3098-101. PMID: 22968466.
      Citations:    
    160. Hoxworth JM, Trentman TL, Kotsenas AL, Thielen KR, Nelson KD, Dodick DW. The role of digital subtraction myelography in the diagnosis and localization of spontaneous spinal CSF leaks. AJR Am J Roentgenol. 2012 Sep; 199(3):649-53. PMID: 22915407.
      Citations:    
    161. Brewer AC, Trentman TL, Ivancic MG, Vargas BB, Rebecca AM, Zimmerman RS, Rosenfeld DM, Dodick DW. Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders. Neuromodulation. 2013 Nov-Dec; 16(6):557-62; discussion 563-4. PMID: 22882274.
      Citations:    
    162. Edelmayer RM, Le LN, Yan J, Wei X, Nassini R, Materazzi S, Preti D, Appendino G, Geppetti P, Dodick DW, Vanderah TW, Porreca F, Dussor G. Activation of TRPA1 on dural afferents: a potential mechanism of headache pain. Pain. 2012 Sep; 153(9):1949-1958. PMID: 22809691.
      Citations:    
    163. Vargas BB, Dodick DW. Posttraumatic headache. Curr Opin Neurol. 2012 Jun; 25(3):284-9. PMID: 22516853.
      Citations:    
    164. Dodick D. The scientific basis of migraine. Cephalalgia. 2012 Apr; 32(5):419. PMID: 22523233.
      Citations:    
    165. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine--classification, characteristics and treatment. Nat Rev Neurol. 2011; 8(3):162-71. PMID: 22331030.
      Citations:    
    166. Dodick DW. Suboccipital steroid injections for cluster headache. Lancet Neurol. 2011 Oct; 10(10):867-9. PMID: 21903478.
      Citations:    
    167. Strand NH, Trentman TL, Vargas BB, Dodick DW. Occipital nerve stimulation with the Bion® microstimulator for the treatment of medically refractory chronic cluster headache. Pain Physician. 2011 Sep-Oct; 14(5):435-40. PMID: 21927047.
      Citations:    
    168. Starling AJ, Hoffman-Snyder C, Halker RB, Wellik KE, Vargas BB, Dodick DW, Demaerschalk BM, Wingerchuk DM. Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist. 2011 Sep; 17(5):297-9. PMID: 21881477.
      Citations:    
    169. Fioravanti B, Kasasbeh A, Edelmayer R, Skinner DP, Hartings JA, Burklund RD, De Felice M, French ED, Dussor GO, Dodick DW, Porreca F, Vanderah TW. Evaluation of cutaneous allodynia following induction of cortical spreading depression in freely moving rats. Cephalalgia. 2011 Jul; 31(10):1090-100. PMID: 21700643.
      Citations:    
    170. Schievink WI, Dodick DW, Mokri B, Silberstein S, Bousser MG, Goadsby PJ. Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective. Headache. 2011 Oct; 51(9):1442-4. PMID: 21658029.
      Citations:    
    171. Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: a response. Headache. 2011 Jun; 51(6):1005-8. PMID: 21592099.
      Citations:    
    172. Aurora S, Diener HC, Dodick D. Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine. J Headache Pain. 2011 Apr; 12(2):137-8. PMID: 21461938.
      Citations:    
    173. Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011 Apr; 51(4):507-17. PMID: 21457235.
      Citations:    
    174. Meng ID, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia. 2011 May; 31(7):851-60. PMID: 21444643.
      Citations:    
    175. Trentman TL, Zimmerman RS, Dodick DW. Occipital nerve stimulation: technical and surgical aspects of implantation. Prog Neurol Surg. 2011; 24:96-108. PMID: 21422780.
      Citations:    
    176. Hewitt DJ, Aurora SK, Dodick DW, Goadsby PJ, Ge YJ, Bachman R, Taraborelli D, Fan X, Assaid C, Lines C, Ho TW. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 2011 Apr; 31(6):712-22. PMID: 21383045.
      Citations:    
    177. Halker RB, Hastriter EV, Dodick DW. Chronic daily headache: an evidence-based and systematic approach to a challenging problem. Neurology. 2011 Feb 15; 76(7 Suppl 2):S37-43. PMID: 21321350.
      Citations:    
    178. Diener HC, Holle D, Dodick D. Treatment of chronic migraine. Curr Pain Headache Rep. 2011 Feb; 15(1):64-9. PMID: 21080112.
      Citations:    
    179. Dodick DW. Journal report from the Editor. Cephalalgia. 2011 Jan; 31(1):3. PMID: 21220380.
      Citations:    
    180. Ho TW, Olesen J, Dodick DW, Kost J, Lines C, Ferrari MD. Antimigraine efficacy of telcagepant based on patient's historical triptan response. Headache. 2011 Jan; 51(1):64-72. PMID: 21054362.
      Citations:    
    181. Almaraz AC, Dilli E, Dodick DW. The effect of prophylactic medications on TMS for migraine aura. Headache. 2010 Nov; 50(10):1630-3. PMID: 21198566.
      Citations:    
    182. Dodick DW, Kost J, Assaid C, Lines C, Ho TW. Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan. Cephalalgia. 2011 Feb; 31(3):296-300. PMID: 20937606.
      Citations:    
    183. Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache. 2010 Oct; 50(9):1406-18. PMID: 20958294.
      Citations:    
    184. Silberstein SD, Dodick DW, Pearlman S. Defining the pharmacologically intractable headache for clinical trials and clinical practice. Headache. 2010 Oct; 50(9):1499-506. PMID: 20958296.
      Citations:    
    185. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011 Feb; 31(3):271-85. PMID: 20861241.
      Citations:    
    186. De Felice M, Ossipov MH, Wang R, Dussor G, Lai J, Meng ID, Chichorro J, Andrews JS, Rakhit S, Maddaford S, Dodick D, Porreca F. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers. Brain. 2010 Aug; 133(Pt 8):2475-88. PMID: 20627971.
      Citations:    
    187. Zarkou S, Dilli E, Dodick DW. 55-Year-old man with thunderclap headache. Mayo Clin Proc. 2010 Jul; 85(7):e44-7. PMID: 20592163.
      Citations:    
    188. Dodick DW, Schembri CT, Helmuth M, Aurora SK. Transcranial magnetic stimulation for migraine: a safety review. Headache. 2010 Jul; 50(7):1153-63. PMID: 20553334.
      Citations:    
    189. Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study. Cephalalgia. 2011 Jan; 31(1):18-30. PMID: 20974598.
      Citations:    
    190. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010 Jun; 50(6):921-36. PMID: 20487038.
      Citations:    
    191. Demaerschalk BM, Bobrow BJ, Raman R, Kiernan TE, Aguilar MI, Ingall TJ, Dodick DW, Ward MP, Richemont PC, Brazdys K, Koch TC, Miley ML, Hoffman Snyder CR, Corday DA, Meyer BC. Stroke team remote evaluation using a digital observation camera in Arizona: the initial mayo clinic experience trial. Stroke. 2010 Jun; 41(6):1251-8. PMID: 20431081.
      Citations:    
    192. Trentman TL, Zimmerman RS, Dodick DW, Dormer CL, Vargas BB. Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literature. J Neurosurg Anesthesiol. 2010 Apr; 22(2):158-62. PMID: 19816202.
      Citations:    
    193. Halker R, Vargas B, Dodick DW. Cluster headache: diagnosis and treatment. Semin Neurol. 2010 Apr; 30(2):175-85. PMID: 20352587.
      Citations:    
    194. Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010 Apr; 9(4):373-80. PMID: 20206581.
      Citations:    
    195. De Felice M, Ossipov MH, Wang R, Lai J, Chichorro J, Meng I, Dodick DW, Vanderah TW, Dussor G, Porreca F. Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol. 2010 Mar; 67(3):325-37. PMID: 20373344.
      Citations:    
    196. Dodick DW. Pearls: headache. Semin Neurol. 2010 Feb; 30(1):74-81. PMID: 20127586.
      Citations:    
    197. Pearlman SH, Dodick DW. Therapeutic guidelines for headache. Handb Clin Neurol. 2010; 97:183-94. PMID: 20816420.
      Citations:    
    198. Diener HC, Johansson U, Dodick DW. Headache attributed to non-vascular intracranial disorder. Handb Clin Neurol. 2010; 97:547-87. PMID: 20816456.
      Citations:    
    199. Dodick DW, Bordini CA. Headache attributed to disorders of homeostasis. Handb Clin Neurol. 2010; 97:627-42. PMID: 20816459.
      Citations:    
    200. Dodick DW. Cephalalgia has flourished over the past 8 years under its publisher, Wiley-Blackwell. Cephalalgia. 2009 Dec; 29(12):1239. PMID: 19895586.
      Citations:    
    201. Holland P, Goadsby P, Dodick D, Valade D. Question & answer session. Cephalalgia. 2009 Dec; 29 Suppl 3:22-4. PMID: 20017751.
      Citations:    
    202. Izenberg A, Aviv RI, Demaerschalk BM, Dodick DW, Hopyan J, Black SE, Gladstone DJ. Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage. Stroke. 2009 Dec; 40(12):3725-9. PMID: 19893001.
      Citations:    
    203. Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache. 2009 Oct; 49(9):1315-23. PMID: 19788472.
      Citations:    
    204. Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache. 2009 Sep; 49(8):1153-62. PMID: 19719543.
      Citations:    
    205. Dodick DW. Migraine triggers. Headache. 2009 Jun; 49(6):958-61. PMID: 19545257.
      Citations:    
    206. Schwedt TJ, Dodick DW. Advanced neuroimaging of migraine. Lancet Neurol. 2009 Jun; 8(6):560-8. PMID: 19446275.
      Citations:    
    207. Vargas BB, Dodick DW. The face of chronic migraine: epidemiology, demographics, and treatment strategies. Neurol Clin. 2009 May; 27(2):467-79. PMID: 19289226.
      Citations:    
    208. Trentman TL, Rosenfeld DM, Vargas BB, Schwedt TJ, Zimmerman RS, Dodick DW. Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894. Pain Physician. 2009 May-Jun; 12(3):621-8. PMID: 19461827.
      Citations:    
    209. Evans RW, Dilli E, Dodick DW. Sentinel headache. Headache. 2009 Apr; 49(4):599-603. PMID: 19338619.
      Citations:    
    210. Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. Clin Ther. 2009 Mar; 31(3):542-59. PMID: 19393844.
      Citations:    
    211. Burstein R, Dodick D, Silberstein S. Migraine prophylaxis with botulinum toxin A is associated with perception of headache. Toxicon. 2009 Oct; 54(5):624-7. PMID: 19344670.
      Citations:    
    212. Demaerschalk BM, Miley ML, Kiernan TE, Bobrow BJ, Corday DA, Wellik KE, Aguilar MI, Ingall TJ, Dodick DW, Brazdys K, Koch TC, Ward MP, Richemont PC. Stroke telemedicine. Mayo Clin Proc. 2009; 84(1):53-64. PMID: 19121244.
      Citations:    
    213. Dodick DW, Schwedt T. Headache: challenging conventional wisdom. Lancet Neurol. 2009 Jan; 8(1):12-4. PMID: 19081504.
      Citations:    
    214. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008 Dec 20; 372(9656):2115-23. PMID: 19036425.
      Citations:    
    215. Vargas BB, Dodick DW, Wingerchuk DM, Demaerschalk BM. Migraine with and without aura and risk for cardiovascular disease. Curr Atheroscler Rep. 2008 Oct; 10(5):427-33. PMID: 18706284.
      Citations:    
    216. Trentman TL, Chan CE, Patel NP, Dodick DW, Nelson KD, Schwedt TJ, Seamans DP. Refractory headaches due to multilevel thoracic cerebrospinal fluid leaks. Pain Pract. 2008 Sep-Oct; 8(5):394-8. PMID: 18694451.
      Citations:    
    217. Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache. 2008 Jul; 48(7):1087-95. PMID: 18687081.
      Citations:    
    218. Dodick DW. Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies? Headache. 2008 Jun; 48(6):828-37. PMID: 18549360.
      Citations:    
    219. Diener HC, Dodick DW. Headache. Curr Opin Neurol. 2008 Jun; 21(3):284-7. PMID: 18451711.
      Citations:    
    220. Dodick DW. CASE 1: the well-intentioned triptan prescriber. Headache. 2008 Jun; 48(6):862-4. PMID: 18549366.
      Citations:    
    221. Pringsheim T, Davenport WJ, Dodick D. Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology. 2008 Apr 22; 70(17):1555-63. PMID: 18427072.
      Citations:    
    222. Dilli E, Dodick DW. Extracephalic cluster (cluster sine headache). Neurology. 2008 Apr 15; 70(16):1362-3. PMID: 18413592.
      Citations:    
    223. Dodick DW. Examining the essence of migraine--is it the blood vessel or the brain? A debate. Headache. 2008 Apr; 48(4):661-7. PMID: 18377395.
      Citations:    
    224. Trentman TL, Dodick DW, Zimmerman RS, Birch BD. Percutaneous occipital stimulator lead tip erosion: report of 2 cases. Pain Physician. 2008 Mar-Apr; 11(2):253-6. PMID: 18354717.
      Citations:    
    225. Vargas BB, Dodick DW. 2007 Scottsdale Headache Symposium. Expert Rev Neurother. 2008 Feb; 8(2):201-4. PMID: 18271707.
      Citations:    
    226. Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database. Headache. 2008 Feb; 48(2):184-93. PMID: 18234045.
      Citations:    
    227. Goadsby PJ, Bartsch T, Dodick DW. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008 Feb; 48(2):313-8. PMID: 18234048.
      Citations:    
    228. Trentman TL, Zimmerman RS, Seth N, Hentz JG, Dodick DW. Stimulation ranges, usage ranges, and paresthesia mapping during occipital nerve stimulation. Neuromodulation. 2008 Jan; 11(1):56-61. PMID: 22150992.
      Citations:    
    229. Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ. The impact of topiramate on health-related quality of life indicators in chronic migraine. Headache. 2007 Nov-Dec; 47(10):1398-408. PMID: 18052949.
      Citations:    
    230. Halker RB, Demaerschalk BM, Wellik KE, Wingerchuk DM, Rubin DI, Crum BA, Dodick DW. Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth. Neurologist. 2007 Sep; 13(5):323-7. PMID: 17848873.
      Citations:    
    231. Dodick D, Roarke M. Familial hemiplegic migraine: permanent attack-related neurologic deficits. Headache. 2007 Sep; 47(8):1210-2. PMID: 17883529.
      Citations:    
    232. Dodick DW. How pain, including headache, becomes chronic. Headache. 2007 Sep; 47(8):1272-4. PMID: 17883550.
      Citations:    
    233. Wingerchuk DM, Spencer B, Dodick DW, Demaerschalk BM. Migraine with aura is a risk factor for cardiovascular and cerebrovascular disease: a critically appraised topic. Neurologist. 2007 Jul; 13(4):231-3. PMID: 17622918.
      Citations:    
    234. Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr Opin Neurol. 2007 Jun; 20(3):310-9. PMID: 17495626.
      Citations:    
    235. Medeiros FL, Medeiros PL, Valença MM, Dodick D. Simvastatin for migraine prevention. Headache. 2007 Jun; 47(6):855-6. PMID: 17578535.
      Citations:    
    236. Diener HC, Kurth T, Dodick D. Patent foramen ovale and migraine. Curr Pain Headache Rep. 2007 Jun; 11(3):236-40. PMID: 17504652.
      Citations:    
    237. Silberstein SD, Dodick D, Freitag F, Pearlman SH, Hahn SR, Scher AI, Lipton RB. Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapy. Headache. 2007 Apr; 47(4):585-99. PMID: 17445108.
      Citations:    
    238. Valença MM, Andrade-Valença LP, da Silva WF, Dodick DW. Hemicrania continua secondary to an ipsilateral brainstem lesion. Headache. 2007 Mar; 47(3):438-41. PMID: 17371363.
      Citations:    
    239. Matharu MS, Schwedt TJ, Dodick DW. Thunderclap headache: an approach to a neurologic emergency. Curr Neurol Neurosci Rep. 2007 Mar; 7(2):101-9. PMID: 17324359.
      Citations:    
    240. Schwedt TJ, Dodick DW. Spontaneous intracranial hypotension. Curr Pain Headache Rep. 2007 Feb; 11(1):56-61. PMID: 17214923.
      Citations:    
    241. Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 Feb; 47(2):170-80. PMID: 17300356.
      Citations:    
    242. Eross E, Dodick D, Eross M. The Sinus, Allergy and Migraine Study (SAMS). Headache. 2007 Feb; 47(2):213-24. PMID: 17300361.
      Citations:    
    243. Dodick DW, Sandrini G, Williams P. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS Drugs. 2007; 21(1):73-82. PMID: 17190530.
      Citations:    
    244. Pascual J, Láinez MJ, Dodick D, Hering-Hanit R. Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review. Headache. 2007 Jan; 47(1):81-9. PMID: 17355498.
      Citations:    
    245. Dodick D, Silberstein S. Central sensitization theory of migraine: clinical implications. Headache. 2006 Nov; 46 Suppl 4:S182-91. PMID: 17078850.
      Citations:    
    246. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache. 2006 Nov; 46 Suppl 4:S202-11. PMID: 17078852.
      Citations:    
    247. Saper JR, Silberstein S, Dodick D, Rapoport A. DHE in the pharmacotherapy of migraine: potential for a larger role. Headache. 2006 Nov; 46 Suppl 4:S212-20. PMID: 17078853.
      Citations:    
    248. Berman GD, Blumenthal HJ, Cady RK, Dodick D, Durham PL, Eross EJ, Levine HL, Lumry WR, Schreiber C, Setzen M. Duplicate publication. Otolaryngol Head Neck Surg. 2006 Sep; 135(3):489-90. PMID: 16949994.
      Citations:    
    249. Schwedt TJ, Matharu MS, Dodick DW. Thunderclap headache. Lancet Neurol. 2006 Jul; 5(7):621-31. PMID: 16781992.
      Citations:    
    250. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine--bringing closure to the subject. Headache. 2006 Apr; 46(4):663-71. PMID: 16643562.
      Citations:    
    251. Capobianco DJ, Dodick DW. Diagnosis and treatment of cluster headache. Semin Neurol. 2006 Apr; 26(2):242-59. PMID: 16628535.
      Citations:    
    252. Boes CJ, Black DF, Dodick DW. Pathophysiology and management of transformed migraine and medication overuse headache. Semin Neurol. 2006 Apr; 26(2):232-41. PMID: 16628534.
      Citations:    
    253. Evans RW, Dodick DW, Schwedt TJ. The headaches that awaken us. Headache. 2006 Apr; 46(4):678-81. PMID: 16643565.
      Citations:    
    254. Schwedt TJ, Dodick DW. Thunderclap stroke: embolic cerebellar infarcts presenting as thunderclap headache. Headache. 2006 Mar; 46(3):520-2. PMID: 16618276.
      Citations:    
    255. Levine HL, Setzen M, Cady RK, Dodick DW, Schreiber CP, Eross EJ, Blumenthal HJ, Lumry WR, Berman GD, Durham PL. An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headache. Otolaryngol Head Neck Surg. 2006 Mar; 134(3):516-23. PMID: 16500456.
      Citations:    
    256. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006 Jan 12; 354(2):158-65. PMID: 16407511.
      Citations:    
    257. Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Headache. 2006 Jan; 46(1):115-24. PMID: 16412159.
      Citations:    
    258. Lin H, Dodick DW. Tearing without pain after trigeminal root section for cluster headache. Neurology. 2005 Nov 22; 65(10):1650-1. PMID: 16301498.
      Citations:    
    259. Silberstein SD, Dodick D, Kesslick J. Removing barriers to appropriate migraine treatment: formulary limitations and triptan package size. Headache. 2005 Oct; 45(9):1250-4. PMID: 16178957.
      Citations:    
    260. Cady RK, Dodick DW, Levine HL, Schreiber CP, Eross EJ, Setzen M, Blumenthal HJ, Lumry WR, Berman GD, Durham PL. Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment. Mayo Clin Proc. 2005 Jul; 80(7):908-16. PMID: 16007896.
      Citations:    
    261. Rozen TD, Saper JR, Sheftell FD, Dodick DW. Clomiphene citrate as a new treatment for SUNCT: hormonal manipulation for hypothalamic-influenced trigeminal autonomic cephalalgias. Headache. 2005 Jun; 45(6):754-6. PMID: 15953310.
      Citations:    
    262. Gladstone JP, Nelson K, Patel N, Dodick DW. Spontaneous CSF leak treated with percutaneous CT-guided fibrin glue. Neurology. 2005 May 24; 64(10):1818-9. PMID: 15911828.
      Citations:    
    263. Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW. Duration of migraine is a predictor for response to botulinum toxin type A. Headache. 2005 Apr; 45(4):308-14. PMID: 15836566.
      Citations:    
    264. Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache. 2005 Apr; 45(4):315-24. PMID: 15836567.
      Citations:    
    265. Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: challenges in clinical practice. Headache. 2005 Apr; 45 Suppl 1:S74-85. PMID: 15833093.
      Citations:    
    266. Sadovsky R, Dodick DW. Identifying migraine in primary care settings. Am J Med. 2005 Mar; 118 Suppl 1:11S-17S. PMID: 15841883.
      Citations:    
    267. Dodick DW. Triptan nonresponder studies: implications for clinical practice. Headache. 2005 Feb; 45(2):156-62. PMID: 15705122.
      Citations:    
    268. Gladstone JP, Dodick DW, Evans R. The young woman with postpartum "thunderclap" headache. Headache. 2005 Jan; 45(1):70-4. PMID: 15663616.
      Citations:    
    269. Gladstone JP, Dodick DW. Migraine and cerebral white matter lesions: when to suspect cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Neurologist. 2005 Jan; 11(1):19-29. PMID: 15631641.
      Citations:    
    270. Dowson AJ, Dodick DW, Limmroth V. Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis. CNS Drugs. 2005; 19(6):483-97. PMID: 15962999.
      Citations:    
    271. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS Drugs. 2005; 19(2):125-36. PMID: 15697326.
      Citations:    
    272. Dodick DW, Lipton RB, Ferrari MD, Goadsby PJ, McCrory D, Cutrer FM, Williams P. Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Curr Pain Headache Rep. 2004 Dec; 8(6):435-42. PMID: 15509456.
      Citations:    
    273. Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther. 2004 Sep; 26(9):1533-45. PMID: 15531016.
      Citations:    
    274. Gladstone JP, Dodick DW. Revised 2004 International Classification of Headache Disorders: new headache types. Can J Neurol Sci. 2004 Aug; 31(3):304-14. PMID: 15376472.
      Citations:    
    275. Gladstone JP, Dodick DW. Painful ophthalmoplegia: overview with a focus on Tolosa-Hunt syndrome. Curr Pain Headache Rep. 2004 Aug; 8(4):321-9. PMID: 15228894.
      Citations:    
    276. Gladstone JP, Dodick DW. From hemicrania lunaris to hemicrania continua: an overview of the revised International Classification of Headache Disorders. Headache. 2004 Jul-Aug; 44(7):692-705. PMID: 15209692.
      Citations:    
    277. Dodick DW, Meissner I, Meyer FB, Cloft HJ. Evaluation and management of asymptomatic carotid artery stenosis. Mayo Clin Proc. 2004 Jul; 79(7):937-44. PMID: 15244395.
      Citations:    
    278. Lipton RB, Dodick DW. CGRP antagonists in the acute treatment of migraine. Lancet Neurol. 2004 Jun; 3(6):332. PMID: 15157847.
      Citations:    
    279. Dodick DW, Martin VT, Smith T, Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache. 2004 May; 44 Suppl 1:S20-30. PMID: 15149490.
      Citations:    
    280. Dodick DW, Lipsy RJ. Advances in migraine management: implications for managed care organizations. Manag Care. 2004 May; 13(5):45-51. PMID: 15181689.
      Citations:    
    281. Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache. 2004 May; 44(5):414-25. PMID: 15147249.
      Citations:    
    282. Dodick DW. Introduction: cardiovascular safety and triptans in the acute treatment of migraine. Headache. 2004 May; 44 Suppl 1:S1-4. PMID: 15149487.
      Citations:    
    283. Blumenfeld AM, Dodick DW, Silberstein SD. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Dermatol Clin. 2004 Apr; 22(2):167-75. PMID: 15222577.
      Citations:    
    284. Gladstone JP, Eross EJ, Dodick DW. Migraine in special populations. Treatment strategies for children and adolescents, pregnant women, and the elderly. Postgrad Med. 2004 Apr; 115(4):39-44, 47-50. PMID: 15095535.
      Citations:    
    285. Dodick DW. Indomethacin-responsive headache syndromes. Curr Pain Headache Rep. 2004 Feb; 8(1):19-26. PMID: 14731379.
      Citations:    
    286. Dodick DW. Preventing migraine pharmacologically. Manag Care Interface. 2004; 17 Suppl D:14-7, 22; discussion 23-30. PMID: 15506041.
      Citations:    
    287. Dodick DW. Epidemiology and acute care of migraine headache. Manag Care Interface. 2004; 17 Suppl D:6-10; discussion 11-3. PMID: 15506040.
      Citations:    
    288. Spierings EL, Rapoport AM, Dodick DW, Charlesworth B. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs. 2004; 18(15):1133-41. PMID: 15581383.
      Citations:    
    289. Dodick D, Blumenfeld A, Silberstein SD. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Clin Dermatol. 2004 Jan-Feb; 22(1):76-81. PMID: 15158549.
      Citations:    
    290. Gladstone JP, Dodick DW. Current and emerging treatment options for migraine and other primary headache disorders. Expert Rev Neurother. 2003 Nov; 3(6):845-72. PMID: 19810888.
      Citations:    
    291. Gladstone J, Eross E, Dodick D. Chronic daily headache: a rational approach to a challenging problem. Semin Neurol. 2003 Sep; 23(3):265-76. PMID: 14722822.
      Citations:    
    292. Dodick DW. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside. Headache. 2003 Jul-Aug; 43 Suppl 1:S25-33. PMID: 12887391.
      Citations:    
    293. Dodick DW. A review of the clinical efficacy and tolerability of almotriptan in acute migraine. Expert Opin Pharmacother. 2003 Jul; 4(7):1157-63. PMID: 12831340.
      Citations:    
    294. Velling DA, Dodick DW, Muir JJ. Sustained-release niacin for prevention of migraine headache. Mayo Clin Proc. 2003 Jun; 78(6):770-1. PMID: 12934790.
      Citations:    
    295. Eross EJ, Dodick DW. Prolonged neurologic complication and MRI abnormalities consequent to intracranial hypotension. Headache. 2003 Apr; 43(4):415. PMID: 12656716.
      Citations:    
    296. Dodick DW, Eross EJ, Parish JM, Silber M. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. 2003 Mar; 43(3):282-92. PMID: 12603650.
      Citations:    
    297. Dodick DW. Sumatriptan versus eletriptan: which is best? Lancet Neurol. 2002 Dec; 1(8):474. PMID: 12849329.
      Citations:    
    298. Dodick DW. Ten most commonly asked questions about headaches associated with spontaneous cerebrospinal fluid leaks... with one bonus question! Neurologist. 2002 Nov; 8(6):371-4. PMID: 12801439.
      Citations:    
    299. Boes CJ, Dodick DW. Refining the clinical spectrum of chronic paroxysmal hemicrania: a review of 74 patients. Headache. 2002 Sep; 42(8):699-708. PMID: 12390632.
      Citations:    
    300. Eross E, Dodick D, Nelson K. "Occult" orthostatic headache. Headache. 2002 Jul-Aug; 42(7):689. PMID: 12482224.
      Citations:    
    301. Dodick DW. Thunderclap headache. Curr Pain Headache Rep. 2002 Jun; 6(3):226-32. PMID: 12003694.
      Citations:    
    302. Hunt CH, Dodick DW, Bosch EP. SUNCT responsive to gabapentin. Headache. 2002 Jun; 42(6):525-6. PMID: 12167143.
      Citations:    
    303. Dodick DW. Debate: analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache. Headache. 2002 Jun; 42(6):547-54. PMID: 12167149.
      Citations:    
    304. Eross EJ, Swanson JW, Dodick DW. Hemicrania continua: an indomethacin-responsive case with an underlying malignant etiology. Headache. 2002 Jun; 42(6):527-9. PMID: 12167144.
      Citations:    
    305. Dodick DW, Eross EJ. A not so uncommon cause of thunderclap headache. Headache. 2002 Jun; 42(6):555. PMID: 12167150.
      Citations:    
    306. Dodick DW. Thunderclap headache. Headache. 2002 Apr; 42(4):309-15. PMID: 12010392.
      Citations:    
    307. Cady R, Dodick DW. Diagnosis and treatment of migraine. Mayo Clin Proc. 2002 Mar; 77(3):255-61. PMID: 11888029.
      Citations:    
    308. Dahlöf CG, Dodick D, Dowson AJ, Pascual J. How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials. Headache. 2002 Feb; 42(2):99-113. PMID: 12005302.
      Citations:    
    309. Dodick D. Patient perceptions and treatment preferences in migraine management. CNS Drugs. 2002; 16 Suppl 1:19-24. PMID: 12196036.
      Citations:    
    310. Dodick DW. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials. Headache. 2002 Jan; 42(1):21-7. PMID: 12005271.
      Citations:    
    311. Dodick DW, Silberstein S, Dahlöf CG. Is there a preferred triptan? Headache. 2002 Jan; 42(1):1-7. PMID: 12005269.
      Citations:    
    Dodick's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (576)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _